Covid-19 (Temas de Saúde Pública)
Riscos de miocardite, pericardite e arritmias cardíacas associadas à vacinação contra COVID-19 vs. infecção por SARS-CoV-2.
15 Dez, 2021 | 12:45hComunicado de imprensa: COVID-19 infection, more likely than vaccines, to cause rare cardiovascular complications – University of Oxford
Comentários no Twitter
Hugely important work from @JuliaHCox and colleagues:
In people <40, Pfizer carries a much lower risk of myocarditis than either Moderna **or SARS-CoV-2 infection** (annotations added)https://t.co/wqRts3ALqy pic.twitter.com/fnn1T39h1b
— David Juurlink (@DavidJuurlink) December 14, 2021
A case series published in @NatureMedicine shows an increased risk of myocarditis after receiving the Astra-Zeneca-Oxford, Pfizer-BioNTech and the Moderna COVID-19 vaccines, but SARS-CoV-2 infection carried a greater risk of myocarditis. https://t.co/6y7pZlJN70 pic.twitter.com/cBlKz9sUkg
— Nature Portfolio (@NaturePortfolio) December 14, 2021
Just published @NatureMedicine
The most comprehensive assessment of the rare events of myocarditis, pericarditis, arrhythmias after COVID and AZ, mRNA vaccineshttps://t.co/0bEdMJSLXg pic.twitter.com/eC5JOx0CmG— Eric Topol (@EricTopol) December 14, 2021
Estudo sugere que os comprovantes de vacinação contra COVID-19 podem reforçar a imunização em países com cobertura vacinal abaixo da média.
15 Dez, 2021 | 12:43hComunicado de imprensa: COVID-19 certificates may boost vaccine uptake in countries with below average coverage – University of Oxford
Estudo original: The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries – The Lancet Public Health
Comentário no Twitter
In our paper @TheLancetPH, @melindacmills and I found that mandatory vaccine passports are effective in increasing vaccine uptake! Already between announcement and introduction, France, Israel and Italy had strong uptick in vaccinations, esp young people: https://t.co/K0xnPdc4o1 https://t.co/WGvhpZjhyo pic.twitter.com/KGCNFmFgVD
— Tobias Rüttenauer (@ruettenauer) December 14, 2021
De disseminação rápida, a variante Ômicron está atualmente em 77 países e a OMS adverte contra presumir que seus efeitos sejam leves.
15 Dez, 2021 | 12:42h[Ainda não publicado] Dados iniciais da África do Sul mostram que, diante de infecção pela variante Ômicron, a proteção vacinal pode cair a 30%, mas ainda impede a doença grave.
15 Dez, 2021 | 12:40hVaccine protection vs. omicron infection may drop to 30% but does cut severe disease – NPR
Ver também: South Africa Omicron study finds drop in vaccine protection, fewer hospitalized – CIDRAP
COVID-19 em 2022: o controle da pandemia está ao nosso alcance.
15 Dez, 2021 | 12:38hCOVID-19 in 2022: controlling the pandemic is within our grasp – Nature Medicine
Comentários no Twitter
What will the COVID-19 pandemic look like in 2022?
Who better to ask than @mvankerkhove, one of the busiest people in the world right now, who took the time to write this thoughtful World View for @NatureMedicine.https://t.co/jgodgPIDrK
— Ben Johnson 🦠📝 (@drbenjohnson) December 14, 2021
Vaccine inequity, inconsistent public health measures and new variants such as Omicron are prolonging the COVID-19 pandemic, but controlling the virus remains possible.
Worldview from @mvankerkhove @WHOhttps://t.co/vLmASqI8i7
— Nature Medicine (@NatureMedicine) December 14, 2021
Ômicron: apresentação técnica atualizada da OMS e ações de prioridade.
14 Dez, 2021 | 16:20h
Comentário no Twitter (fio – clique para saber mais)
🆕 Technical Brief & Priority Actions for Member States on enhancing readiness for Omicron https://t.co/tOu6iIvFZP #COVID19 pic.twitter.com/huPP4QFS35
— World Health Organization (WHO) (@WHO) December 12, 2021
Recomendações para uma recuperação equitativa da pandemia de COVID-19 no Canadá.
14 Dez, 2021 | 16:16hComunicado de imprensa: Equitable COVID-19 pandemic recovery in Canada: New guideline – Canadian Medical Association Journal
Editorial: Build back more equitably
[Preprint] Variante Ômicron do SARS-CoV-2 escapa da neutralização via soro de pessoas vacinadas e convalescentes.
14 Dez, 2021 | 16:15hComentário: SARS-CoV-2 omicron variant may evade host immune responses – News Medical
Comentário no Twitter (fio – clique para saber mais)
⚠️OMICRON “EVADES” NEUTRALIZATION—1st ever #Omicron variant study of blood from Moderna, Oxford-AstraZeneca, Pfizer vaccinated, vs survivors of Alpha, Beta, Delta variants. Omicron #B11529 evasive—but 2x Pfizer/mixed stronger>> convalescent; 3x hit best.🧵 https://t.co/292o740rHy pic.twitter.com/NYei6MACkj
— Eric Feigl-Ding (@DrEricDing) December 13, 2021
[Preprint] Vacinas contra COVID eliminam o risco de transmissão da variante Delta – mas não por muito tempo.
14 Dez, 2021 | 16:12hCOVID vaccines cut the risk of transmitting Delta — but not for long – Nature
Estudo original [preprint]: The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission – medRxiv
Relatório do Reino Unido sobre as variantes de preocupação do SARS-CoV-2 mostra efetividade da vacina (EV) significativamente menor contra infecção pela Ômicron, porém uma EV moderada a alta (70 a 75%) após uma terceira dose (reforço).
13 Dez, 2021 | 11:43hComentários:
Omicron: Three vaccine doses key for protection against variant – BBC
Two jabs offer little protection against Omicron infection, UK data shows – The Guardian
UK Says Omicron to Become Its Dominant Variant Within Days – Associated Press